Plan for amended pharmaceutical affairs law might hit snag

Published: 2004-11-09 07:00:00

Updated: 2004-11-09 07:00:00

Political sources said the government's intended revision of Korea Pharmaceutical Affairs Law, including introduction of corporation pharmacy and establishment of drug information center towards January of next year, might be delayed, as regular Assembly sessions have been halted for nine days du...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK